Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Irbesartan and Hydrochlorothiazide Tablets

Approval Number

国药准字H20233450

Company江苏中治制药有限公司

Registration Date

April 11, 2023

Drug Information

Generic Name

厄贝沙坦氢氯噻嗪片

Dosage Form

片剂

Strength

每片含厄贝沙坦150mg，氢氯噻嗪12.5mg。

Drug Type

化学药品

Registration Date

April 11, 2023

Company Information

Applicant Company

Company Name江苏中治制药有限公司

Company Address

泰州市药城大道1号（药城大道南侧、口泰路东侧）C1幢1411室

Manufacturing Company

Company Name江苏长江药业有限公司

Company Address

江苏射阳县城红旗路28号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy